Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonists
- PMID: 9609565
- DOI: 10.1016/s0002-9378(98)70529-0
Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonists
Abstract
Objective: We sought to test the hypothesis that an intravenous dose of H-Tyr-D-Arg-Phe-Lys-NH2, a highly mu-receptor selective opioid peptide, suppresses baroreflex sensitivity through a peripheral mechanism.
Study design: A transient change in mean arterial pressure was produced in chronically instrumented pregnant ewes by norepinephrine or sodium nitroprusside in the absence or in the presence of H-Tyr-D-Arg-Phe-Lys-NH2, a highly mu-selective opioid peptide. In some studies naloxone methiodide, a peripheral opioid antagonist, was infused starting 60 minutes before the administration of H-Tyr-D-Arg-Phe-Lys-NH2 and maintained for a total of 90 minutes. Linear plots were obtained when the changes in mean arterial pressure during the pressure rise were plotted against the changes in heart rate and the sensitivity of the baroreflex was derived as the slope of the linear regression line.
Results: We observed (1) lower baroreflex sensitivity after H-Tyr-D-Arg-Phe-Lys-NH2 administration with a hypertensive stimulus; (2) unchanged baroreflex sensitivity after H-Tyr-D-Arg-Phe-Lys-NH2 administration with a hypotensive stimulus; and (3) unchanged baroreflex sensitivity after H-Tyr-D-Arg-Phe-Lys-NH2 administration with a hypertensive stimulus in the presence of naloxone methiodide.
Conclusion: H-Tyr-D-Arg-Phe-Lys-NH2 suppresses the hypertensive but not the hypotensive arm of the baroreflex through peripheral opioid receptors. These results suggest that mu-opioid receptors are present in the vagus nerves and that the activation of these opioid receptors inhibits reflex bradycardia in pregnant sheep.
Similar articles
-
Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia.Circulation. 2002 May 28;105(21):2518-23. doi: 10.1161/01.cir.0000017186.52382.f4. Circulation. 2002. PMID: 12034659 Review.
-
A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonists.J Cardiovasc Pharmacol. 2000 Feb;35(2):269-74. doi: 10.1097/00005344-200002000-00014. J Cardiovasc Pharmacol. 2000. PMID: 10672860
-
Cardiovascular effects of a mu-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: sites and mechanisms of action.Am J Obstet Gynecol. 1999 May;180(5):1127-30. doi: 10.1016/s0002-9378(99)70605-8. Am J Obstet Gynecol. 1999. PMID: 10329866
-
Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists.J Cardiovasc Pharmacol. 1998 Jun;31(6):954-9. doi: 10.1097/00005344-199806000-00021. J Cardiovasc Pharmacol. 1998. PMID: 9641482
-
The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.Mol Pharmacol. 1996 Sep;50(3):650-5. Mol Pharmacol. 1996. PMID: 8794906
Cited by
-
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.Med Res Rev. 2016 Sep;36(5):871-923. doi: 10.1002/med.21395. Epub 2016 May 16. Med Res Rev. 2016. PMID: 27197922 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials